486-63-5
486-63-5
Chemical Structure
Isoformononetin
- CAS No.: 486-63-5
- Formula:C16H12O4
- Molecular Weight:268.26
IUPAC Name: 3-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one
InChIKey: LNIQZRIHAMVRJA-UHFFFAOYSA-N
SMILES: O=C1C(C2=CC=C(O)C=C2)=COC3=CC(OC)=CC=C13
Biological Activity: Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Isoformononetin | 99.47% | Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Isoformononetin (Standard) | ≥98% | Isoformononetin (Standard) is the analytical standard of Isoformononetin. This product is intended for research and analytical applications. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Isoformononetin-d3 | 98.64% | Isoformononetin-d3 is the deuterium labeled Isoformononetin (HY-N7501). Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Texasin | 99.14% | Texasin is a natural product that can be isolated from Baptisia australis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ipriflavone metabolites IV | Ipriflavone metabolites IV is a metabolite of Ipriflavone (HY-N0094). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycitein (Standard) | ≥98% | Glycitein (Standard) is the analytical standard of Glycitein. This product is intended for research and analytical applications. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Daidzein | 99.81% | Daidzein is a soy isoflavone, which acts as a PPAR activator. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Formononetin (Standard) | 98.79% | Formononetin (Standard) is the analytical standard of Formononetin. This product is intended for research and analytical applications. Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4',7-Dimethoxyisoflavone | 98.61% | 4',7-Dimethoxyisoflavone is isolated from the leaves of Albizzia lebbeck, which shows antifungal activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Prunetin | 99.01% | Prunetin, an O-methylated isoflavone, possesses anti-inflammatory activity. Prunetin is a potent human aldehyde dehydrogenases inhibitor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Deoxycajanin | 5-Deoxycajanin (Compound 4) is a flavonoid and can be isolated from Eschscholtzia californica. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
7-Methoxyisoflavone | 99.47% | 7-Methoxyisoflavone is an isoflavone derivative and also an activator of adenosine monophosphate-activated protein kinase (AMPK). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
7-Hydroxy-3-(3-methoxyphenyl)-4H-chromen-4-one | 7-Hydroxy-3-(3-methoxyphenyl)-4H-chromen-4-one is a dual agonist of PPARα and PPARγ, with an EC50 of 23.10 μM for human PPARα and an EC50 of 22.29 μM for human PPARγ. 7-Hydroxy-3-(3-methoxyphenyl)-4H-chromen-4-one regulates the expression of lipid metabolism-related genes via PPARα, and modulates the expression of genes associated with glucose homeostasis and adipogenesis via PPARγ. 7-Hydroxy-3-(3-methoxyphenyl)-4H-chromen-4-one can be used in the research of type 2 diabetes and metabolic syndrome. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
